|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Umbilical cord blood pH and Apgar scores as an index of neonatal health显示文摘 | Josten BE Johnson TR Nelson JP | 1987 | Am J Obstet Gynecol1987，157，41： | 1 |
| 2 | The American customer satisfaction index:nature,purpose,and findings显示文摘 | Fornell C Johnson MD Anderson EW Cha J Bryant BE | 1996 | The Journal of Mar_ket_ing1996，60，： | 1 |
| 3 | Mutations in the epidermal growth factor receptor and in KRAS are predictive and prognostic indicators in patients with non-small-cell lung cancer treated with chemotherapy alone and in combination with Erlotinib 显示文摘 | Eberhard DA Johnson BE Amler LC | 2005 | J Clin Oncol2005，23，： | 1 |
| 4 | Local anesthetics as anti- microbial agents 显示文摘 | Johnson SM Saint BE Dine AP | 2008 | Surg Infect : Larchmt2008，9，2： | 1 |
| 5 | Phase Ⅱ study of imatinib in patients with small cell lung cancer显示文摘 | Johnson BE Fischer T Fischer B | 2003 | Clin Cancer Res2003，9，： | 1 |
| 6 | Protection against cisplatin-induced nephrotoxicity by a carbon monoxidereleasing molecule显示文摘 | Tayem Y Johnson TR Mann BE | 2006 | Am J Physiol Renal Physiol2006，290，4： | 1 |
| 7 | A randomized,placebo-controlled phasc Ⅱ study of vandctanib plus docetaxel in previously treated non-small-cell lung cancer显示文摘 | Heymach JV Johnson BE Parger D | | 0，，11： | 1 |
| 8 | Randomized, placebo controlled phase Ⅱ study of vandetanib plus docetaxel in previously treated non small-cell lung cancer 显示文摘 | Heymach JV Johnson BE Prager D | 2007 | J Clin Oncol2007，25，27： | 1 |
| 9 | Expression of Bcl-2 protein is associated with shorter survival in nonsmall cell lung carcinoma显示文摘 | Huang CI Neuberg D Johnson BE | 2003 | Cancer2003，98，1： | 1 |
| 10 | Randomized, placebo-controlled phase II study of vandetanib plus docetaxel in previously treated non small-cell lung cancer显示文摘 | Heymach JV Johnson BE Prager D | 2007 | J Clin Oneol2007，25，27： | 1 |
| 11 | Basic treatment considerations using chemotherapy for patients with small cell lung cancer显示文摘 | Johnson BE Janne PA | 2004 | Hematol Oncol Clin North Am2004，18，2： | 1 |
| 12 | Adjuvant chemotherapy for surgically resected non-small cell lung cancer 显示文摘 | Heon S Johnson BE | 2012 | J Thorac Cardiovasc Surg2012，144，3： | 1 |
| 13 | Mutations in the epidermal growth factor receptor and in K-ras are predictive and prognostic indicators in patients with non-small-cell lung cancer treated with chemotherapy alone and in combination with erlotinib显示文摘 | Eberhard DA Johnson BE Amler LC | 2005 | J Clin Oncol2005，23，25： | 1 |
| 14 | Rationale for a phase II trial of pertuzumab,a HER-2 dimerization inhibitor,in patients with non-small cell lung cancer显示文摘 | Johnson BE Janne PA | 2006 | Clin Cancer Res2006，12，14： | 1 |
| 15 | Clinical and laboratory studies of the photosensitizing potential of norfloxacin,a 4-quinolone broad-spectrum antibiotic显示文摘 | Ferguson J Johnson BE | 1993 | Br J Dermatol1993，128，： | 1 |
| 16 | Basic treatment considerations us-ing chemotherapy for patients with smal cel lung cancer显示文摘 | Johnson BE J?nne PA | | 0，，02： | 1 |
| 17 | Randomized, placebo-controlled phase II study of vandetanib plus docetaxel in previously treated non small-celllung cancer显示文摘 | Heymach JV Johnson BE Prager D | 2008 | Clin Oneol2008，26，1： | 1 |
| 18 | Neurologic, computed cranial tomographic, and magnetic resonance imaging abnormalities in patients with small-cell lung cancer: further follow-up of 6- to 13-year survivors显示文摘 | Patronas N Hayes W | 1990 | Clin Oncol1990，8，1： | 1 |
| 19 | Management of small cell lung cancer 显示文摘 | Johnson BE | 2002 | Clin Chest Med2002，23，1： | 1 |
| 20 | Metal carbonyls as pharmaceuticals? , a CO-releasing molecule with an extensive aqueous solution chemistry 显示文摘 | Johnson TR Mann BE Teasdale IP | 2007 | Dalton Trans2007，15，： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员